Treating PD GBA-N370S iPSC-derived dopamine neurons with the HDAC4 allosteric inhibitor tasquinimod or the representative PP2A inhibitor cantharidin corrected the increase in autophagosome number assessed by LC3-II levels (Figure 6A) through decreased autophagic induction rather than increasing flux (Figures S7B–S7D), reduced the increase in lysosomal accumulation measured by LAMP1 (Figures 6B and 6C), increased lysosomal activity (Figure 6D), and reduced the increased release of α-synuclein into the extracellular medium (Figure 6E). The gene discussed is PTPA; the disease is Parkinson disease.